Advances in Lung Cancer

Vol.2 No.4(2013), Paper ID 40505, 5 pages

DOI:10.4236/alc.2013.24011

 

Circulating IgG antibody against FOXP3 may be a potential biomarker for lung cancer

 

Weili Wang, Leiguang Ye, Xiaomei Li, Songlei Guan, Shilong Sun, Meng Wang, Xueqing Guan, Kuang-Hui Lee, Jun Wei, Baogang Liu

 

Department of Radiobiology, School of Public Health, Jilin University, Changchun, China
Department of Pulmonary Oncology, The Third Affiliated Hospital of Harbin Medical University, Harbin, China
Department of Pulmonary Oncology, The Third Affiliated Hospital of Harbin Medical University, Harbin, China
Department of Radiobiology, School of Public Health, Jilin University, Changchun, China
Department of Radiobiology, School of Public Health, Jilin University, Changchun, China
Department of Pulmonary Oncology, The Third Affiliated Hospital of Harbin Medical University, Harbin, China
Department of Pulmonary Oncology, The Third Affiliated Hospital of Harbin Medical University, Harbin, China
Pei-Ling Guan-Si Hospital, Hsinchu
Department of Diabetes & Cardiovascular Science, University of the Highlands & Islands, Centre for Health Science, Inverness, UK
Department of Pulmonary Oncology, The Third Affiliated Hospital of Harbin Medical University, Harbin, China

 

Copyright © 2013 Weili Wang, Leiguang Ye, Xiaomei Li, Songlei Guan, Shilong Sun, Meng Wang, Xueqing Guan, Kuang-Hui Lee, Jun Wei, Baogang Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Wang, W. , Ye, L. , Li, X. , Guan, S. , Sun, S. , Wang, M. , Guan, X. , Lee, K. , Wei, J. and Liu, B. (2013) Circulating IgG antibody against FOXP3 may be a potential biomarker for lung cancer. Advances in Lung Cancer, 2, 79-83. doi: 10.4236/alc.2013.24011.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.